Randomized phase II trial of Gemcitabine and Paclitaxel with or without maintenance treatment in patients with cisplatin refractory transitional cell carcinoma

被引：0
|
作者：
Fechner, GH
Siener, R
Reimann, M
Strunk, R
Golinski, C
Heimbach, D
Wiebusch, H
Langbein, S
Ehlert, C
Bannowsky, A
Heidenreich, A
Kühn, M
Albers, P
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [31] A phase II trial of paclitaxel and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
    Papadimitriou, C
    Dimopoulos, MA
    Moulopoulos, L
    Sarris, K
    Fountzilas, G
    Voulgaris, Z
    Anagnostopoulos, A
    Athanassiades, P
    Stamatelopoulos, S
    ANNALS OF ONCOLOGY, 1998, 9 : 73 - 73
  • [32] A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma.
    Pal, Sumanta K.
    Mortazavi, Amir
    Milowsky, Matthew I.
    Vaishampayan, Ulka N.
    Parikh, Mamta
    Lyou, Yung
    Wang, Peng
    Parikh, Rahul Atul
    Teply, Benjamin A.
    Dreicer, Robert
    Emamekhoo, Hamid
    Michaelson, M. Dror
    Hoimes, Christopher J.
    Zhang, Tian
    Srinivas, Sandy
    Kim, William Y.
    Liu, Glenn
    Frankel, Paul Henry
    Cui, Yuijie
    Lara, Primo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
    Joaquín Casal Rubio
    S. Vázquez
    F. Vázquez
    M. Amenedo
    J. L. Fírvida
    J. R. Mel
    G. Huidobro
    E. Álvarez
    M. Lázaro
    G. Alonso
    I. Fernández
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 379 - 384
  • [34] A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
    Casal Rubio, Joaquin
    Vazquez, S.
    Vazquez, F.
    Amenedo, M.
    Firvida, J. L.
    Mel, J. R.
    Huidobro, G.
    Alvarez, E.
    Lazaro, M.
    Alonso, G.
    Fernandez, I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 379 - 384
  • [35] Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Sheinfeld, J
    Mazumdar, M
    Tong, W
    Rabbani, F
    Donat, SM
    Herr, HW
    Sogani, P
    Depalma, D
    Bajorin, D
    JOURNAL OF UROLOGY, 2002, 167 (04): : 186 - 186
  • [36] Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus
    Ilson, DH
    Ajani, J
    Bhalla, K
    Forastiere, A
    Huang, Y
    Patel, P
    Martin, L
    Donegan, J
    Pazdur, R
    Reed, C
    Kelsen, DP
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1826 - 1834
  • [37] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Nong Xu
    Xiao Chen Zhang
    Jian Ping Xiong
    Wei Jia Fang
    Lan Fang Yu
    Jiong Qian
    Ling Zhang
    BMC Cancer, 7
  • [38] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Xu, Nong
    Zhang, Xiao Chen
    Xiong, Jian Ping
    Fang, Wei Jia
    Yu, Lan Fang
    Qian, Jiong
    Zhang, Ling
    BMC CANCER, 2007, 7 (1)
  • [39] Gemcitabine and paclitaxel in previously treated patients with advanced transitional cell carcinoma
    Marini, L
    Sternberg, C
    Sella, A
    Calabro, F
    Van Rijn, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S348 - S349
  • [40] Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
    Shin, DM
    Glisson, BS
    Khuri, FR
    Ginsberg, L
    Papadimitrakopoulou, V
    Lee, JJ
    Lawhorn, K
    Gillenwater, AM
    Ang, KK
    Clayman, GL
    Callender, DL
    Hong, WK
    Lippman, SM
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1325 - 1330
12345